Luts & Greenleigh Group, Inc Abb Vie Inc. Transaction History
Luts & Greenleigh Group, Inc
- $104 Billion
- Q3 2024
A detailed history of Luts & Greenleigh Group, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Luts & Greenleigh Group, Inc holds 13,757 shares of ABBV stock, worth $2.45 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
13,757
Previous 13,626
0.96%
Holding current value
$2.45 Million
Previous $2.34 Billion
16.24%
% of portfolio
2.61%
Previous 2.43%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,853Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.1 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.31 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.89 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $315B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...